NEUROENDOCRINE CARCINOMA OF THE CERVIX

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting NEUROENDOCRINE CARCINOMA OF THE CERVIX:

# Drug Count
0 BEVACIZUMAB 7
1 TACROLIMUS 6
2 TACROLIMUS EXTENDED-RELEASE CAPSULES 6
3 TACROLIMUS OINTMENT 0.1% 6
4 PACLITAXEL 5
5 TOPOTECAN 5
6 CISPLATIN 3
7 ETOPOSIDE 3
8 IPILIMUMAB 3
9 DURVALUMAB 2
See all common drugs associated with NEUROENDOCRINE CARCINOMA OF THE CERVIX

NEUROENDOCRINE CARCINOMA OF THE CERVIX is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLATINUM 2 0.0038
1 TOPOTECAN 5 0.0008
2 EVEROLIMUS TABLETS 2 0.0001
3 DURVALUMAB 2 0.0001
4 PEGFILGRASTIM 1 0.0001
5 IPILIMUMAB 3 0.0001
6 BEVACIZUMAB 7 0.0001
7 PACLITAXEL 5 0.0000
8 HUMAN IMMUNOGLOBULIN G 1 0.0000
9 TACROLIMUS OINTMENT 0.1% 6 0.0000
See all drugs enriched for association with NEUROENDOCRINE CARCINOMA OF THE CERVIX